Chase Sun

Tianjin Hongri Pharmaceutical Co., Ltd. was founded in September 1996 and successfully landed on the GEM in October 2009. The company takes the road of high-tech industrialization, takes the research and development of refined drugs and produces good medicines as its own responsibility, adheres to steady development, and constantly builds core competitiveness. At present, Hongri Pharmaceutical has developed into a wide range of fields, including modern Chinese medicine, chemical synthetic drugs, biotechnology drugs, pharmaceutical excipients and APIs, medical devices, medical health services, etc., integrating investment, financing, research and development, production and sales.